Who Supplies Telmisartan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Telmisartan exports, with 413+ registered manufacturers shipping to buyers across 132+ countries — yet a handful of companies dominate the shipments. CIPLA LIMITED holds the largest share at 98.4% (export value: $10.8B). Close behind, MYLAN LABORATORIES LIMITED (0.5%, $58.2M). INTAS PHARMACEUTICALS LIMITED (0.1%, $14.4M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Telmisartan? Top Manufacturers & Their Buyers
Flow of Telmisartan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Telmisartan Supplier Network — Key Market Intelligence
The Telmisartan export market from India is led by CIPLA LIMITED, which alone commands a 98.4% share, shipping $10.8B worth of product across 1.6K shipments. The second-largest exporter, MYLAN LABORATORIES LIMITED, contributes $58.2M (0.5%) to the overall market. Combined, the top two suppliers alone account for 98.9% of all Telmisartan exports, indicating a relatively concentrated supply base.
Across all 413 tracked manufacturers, the total Telmisartan export value stands at $11.0B from 11.1K shipments. The market average shipment value is $990.0K. The single largest buyer relationship in terms of trade value is B LOGISTIK GMBH, receiving $10.8B worth of product.
The combined buyer network spans 21 named purchasing companies, including B LOGISTIK GMBH, BREATHEFREE LANKA PVT LTD, BOEHRINGER INGELHEIM, IBL LIMITED - Health, MYLAN HUNGARY KFT, and 16 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1CIPLA LIMITED
CIPLA LIMITED is the first-largest Telmisartan exporter from India, with a market share of 98.4% and a total export value of $10.8B across 1.6K shipments. Their average shipment value of $6.7M is above the market average of $990.0K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. B LOGISTIK GMBH is the dominant customer, accounting for 99.9% of this supplier's tracked business. Top customers include:
• B LOGISTIK GMBH — $10.8B across 1.6K shipments (99.9% of this supplier's total exports)
• B LOGISTIK GMBH — $6.5M across 1 shipments (0.1% of this supplier's total exports)
• BREATHEFREE LANKA PVT LTD — $1.6M across 0 shipments (0.0% of this supplier's total exports)
• BOEHRINGER INGELHEIM — $179.2K across 0 shipments (0.0% of this supplier's total exports)
• IBL LIMITED - Health — $82.3K across 0 shipments (0.0% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $6.7M is 573% above the market average of $990.0K, consistent with large-order contracts or value-added formulations.
2MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the second-largest Telmisartan exporter from India, with a market share of 0.5% and a total export value of $58.2M across 240 shipments. Their average shipment value of $242.4K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN HUNGARY KFT, is the dominant customer, accounting for 76.5% of this supplier's tracked business. Top customers include:
• MYLAN HUNGARY KFT, — $44.5M across 184 shipments (76.5% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $11.1M across 46 shipments (19.1% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $1.4M across 6 shipments (2.4% of this supplier's total exports)
• MYLAN HUNGARY KFT, — $957.8K across 4 shipments (1.6% of this supplier's total exports)
• MYLAN HUNGARY KFT, — $185.4K across 1 shipments (0.3% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (240 shipments) at a per-shipment value of $242.4K, indicating a broad distribution network with many smaller, regular orders.
3INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the third-largest Telmisartan exporter from India, with a market share of 0.1% and a total export value of $14.4M across 461 shipments. Their average shipment value of $31.2K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. LABORATORIOS SAVAL S.A. is the dominant customer, accounting for 60.6% of this supplier's tracked business. Top customers include:
• LABORATORIOS SAVAL S.A. — $8.7M across 280 shipments (60.6% of this supplier's total exports)
• ACCORD FARMA S.A. DE C.V. — $3.1M across 101 shipments (21.9% of this supplier's total exports)
• ACCORD FARMA S.A. DE C.V. — $1.6M across 52 shipments (11.3% of this supplier's total exports)
• TO THE ORDER — $600.5K across 19 shipments (4.2% of this supplier's total exports)
• RITEMED PHILS., INC. — $286.5K across 9 shipments (2.0% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (461 shipments) at a per-shipment value of $31.2K, indicating a broad distribution network with many smaller, regular orders.
4ARISTO PHARMACEUTICALS PRIVATE LIMITED
ARISTO PHARMACEUTICALS PRIVATE LIMITED is the fourth-largest Telmisartan exporter from India, with a market share of 0.1% and a total export value of $10.9M across 334 shipments. Their average shipment value of $32.5K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.
ARISTO PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. NORVIK ENTERPRISES is the dominant customer, accounting for 90.7% of this supplier's tracked business. Top customers include:
• NORVIK ENTERPRISES — $9.8M across 303 shipments (90.7% of this supplier's total exports)
• NORVIK ENTERPRISES — $594.2K across 18 shipments (5.5% of this supplier's total exports)
• PHARMAVISION LTD — $229.9K across 7 shipments (2.1% of this supplier's total exports)
• ADK PHARMACEUTICAL C — $113.4K across 3 shipments (1.0% of this supplier's total exports)
• SOUTH AMERICAN EXPRE — $75.5K across 2 shipments (0.7% of this supplier's total exports)
Key Insight: ARISTO PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (334 shipments) at a per-shipment value of $32.5K, indicating a broad distribution network with many smaller, regular orders.
5ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the fifth-largest Telmisartan exporter from India, with a market share of 0.1% and a total export value of $6.8M across 251 shipments. Their average shipment value of $27.0K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• APOTEX PTY LTD. — $2.9M across 107 shipments (42.6% of this supplier's total exports)
• RANBAXY PHARMACEUTICALS — $1.6M across 61 shipments (24.2% of this supplier's total exports)
• PHARMA VISION PTY LT — $1.0M across 38 shipments (15.1% of this supplier's total exports)
• APOTEX PTY LIMITED — $703.5K across 26 shipments (10.4% of this supplier's total exports)
• ARROW PHARMACEUTICAL — $524.2K across 19 shipments (7.7% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (251 shipments) at a per-shipment value of $27.0K, indicating a broad distribution network with many smaller, regular orders.
6GLENMARK PHARMACEUTICALS LIMITED
GLENMARK PHARMACEUTICALS LIMITED is the fifth-largest Telmisartan exporter from India, with a market share of 0.0% and a total export value of $3.4M across 532 shipments. Their average shipment value of $6.4K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.
GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• GLENMARK PHARMACEUTICALS INC., USA — $1.1M across 171 shipments (32.1% of this supplier's total exports)
• EGIS PHARMACEUTICALS PLC EGIS NYRT. — $1.1M across 169 shipments (31.7% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC., USA — $549.9K across 85 shipments (16.0% of this supplier's total exports)
• EG S.P.A — $357.8K across 55 shipments (10.4% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC., USA — $334.0K across 52 shipments (9.7% of this supplier's total exports)
Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (532 shipments) at a per-shipment value of $6.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Telmisartan Flows
Once Telmisartan leaves the manufacturing plants of companies like CIPLA LIMITED and MYLAN LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $11.0B. Germany absorbs the largest share at 98.4% ($10.8B), followed by Hungary (0.5%) and United States (0.2%).
In Germany — the top destination — named importers include B LOGISTIK GMBH. In Hungary, key buyers are MYLAN HUNGARY KFT,, TEVA PHAMACEUTICALS WORKS.
This geographic spread reflects Telmisartan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Telmisartan Go? Top Importing Countries & Their Buyers
Trade flow of Telmisartan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany ranks as the first-largest destination for Telmisartan imports from India, with a total trade value of $10.8B across 1,540 shipments — representing a 98.4% share of all Telmisartan exports. The average shipment value of $7.0M is above the global average of $990.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Telmisartan importers in Germany: B LOGISTIK GMBH is the largest buyer, accounting for 100.0% ($10.8B) of this market's total imports.
• B LOGISTIK GMBH — $10.8B (100.0% of Germany's total)
Key Insight: Germany's per-shipment average of $7.0M (608% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Telmisartan imports from India.
2Hungary
Hungary ranks as the second-largest destination for Telmisartan imports from India, with a total trade value of $50.5M across 112 shipments — representing a 0.5% share of all Telmisartan exports. The average shipment value of $451.0K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Telmisartan importers in Hungary: MYLAN HUNGARY KFT, is the largest buyer, accounting for 90.2% ($45.5M) of this market's total imports.
• MYLAN HUNGARY KFT, — $45.5M (90.2% of Hungary's total)
• TEVA PHAMACEUTICALS WORKS — $2.8M (5.5% of Hungary's total)
Key Insight: Hungary receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Hungary is a key market for Telmisartan imports from India.
3United States
United States ranks as the third-largest destination for Telmisartan imports from India, with a total trade value of $26.6M across 247 shipments — representing a 0.2% share of all Telmisartan exports. The average shipment value of $107.5K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.
Named Telmisartan importers in United States: MYLAN PHARMACEUTICALS INC, is the largest buyer, accounting for 46.7% ($12.4M) of this market's total imports.
• MYLAN PHARMACEUTICALS INC, — $12.4M (46.7% of United States's total)
• GLENMARK PHARMACEUTICALS INC., USA — $2.6M (10.0% of United States's total)
• ASCEND LABORATORIES LLC — $2.3M (8.7% of United States's total)
Key Insight: United States receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
United States is a key market for Telmisartan imports from India.
4Uganda
Uganda ranks as the fourth-largest destination for Telmisartan imports from India, with a total trade value of $11.8M across 177 shipments — representing a 0.1% share of all Telmisartan exports. The average shipment value of $66.6K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Telmisartan importers in Uganda: NORVIK ENTERPRISES LIMITED is the largest buyer, accounting for 91.9% ($10.8M) of this market's total imports.
• NORVIK ENTERPRISES LIMITED — $10.8M (91.9% of Uganda's total)
Key Insight: Uganda receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Uganda is a key market for Telmisartan imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Telmisartan imports from India, with a total trade value of $10.1M across 19 shipments — representing a 0.1% share of all Telmisartan exports. The average shipment value of $530.8K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Telmisartan importers in Philippines: EUROASIA PHARMACEUTICALS INC is the largest buyer, accounting for 50.6% ($5.1M) of this market's total imports.
• EUROASIA PHARMACEUTICALS INC — $5.1M (50.6% of Philippines's total)
Key Insight: Philippines receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Philippines is a key market for Telmisartan imports from India.
People Also Ask — Telmisartan Supplier & Trade Network
Who are the top suppliers of Telmisartan from India?+
Which companies buy Telmisartan from Indian manufacturers?+
Where does Telmisartan exported from India go?+
What is the market share of the top Telmisartan supplier from India?+
What is the average shipment value for Telmisartan exports from India?+
Is Telmisartan manufactured in India and exported globally?+
Which country imports the most Telmisartan from India?+
Who are the buyers of Telmisartan in Hungary?+
How concentrated is the Telmisartan supplier market in India?+
How do I find verified buyers for Telmisartan in specific countries?+
Telmisartan Trade Network — Key Takeaways
- 1CIPLA LIMITED is India's dominant Telmisartan exporter with a 98.4% market share and $10.8B in total exports — making it the single most important sourcing entity in this market.
- 2The top 413 suppliers collectively account for 99.2% of all tracked Telmisartan exports, with a combined trade value of $11.0B.
- 3Germany is the largest destination market, absorbing 98.4% of India's Telmisartan exports ($10.8B). Hungary (0.5%) and United States (0.2%) follow.
- 4With 11.1K total shipments averaging $990.0K each, the Telmisartan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include B LOGISTIK GMBH, B LOGISTIK GMBH, MYLAN HUNGARY KFT,, MYLAN PHARMACEUTICALS INC, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 132 countries
Network value: $11.0B
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Telmisartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Telmisartan.
- 2.Flow Mapping: 413 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 11,086 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 132 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11,086 Verified Shipments
413 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists